There can also be limited patent time left for compounds that failed in later stages, limiting return on investments ROI in drug repurposing online cialis Finally, EGFR inhibitors, Gefitinib and Erlotinib, and Src inhibitor, Dasatinib, are all shown to reduce the levels of SOX2 by blocking the EGFR SRC AKT signaling, eventually suppressing the self renewal properties of cancer stem cells in non small cell lung cancer Singh et al
.
.
